{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:07:31Z","timestamp":1772204851273,"version":"3.50.1"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006292","name":"Infectious Diseases Society of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0207582","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T14:51:02Z","timestamp":1542293462000},"page":"e0207582","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["A scoring strategy for progression risk and rates of treatment completion in subjects with latent tuberculosis"],"prefix":"10.1371","volume":"13","author":[{"given":"Michael","family":"Scolarici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Dekitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia","family":"Sokol-Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F.","family":"Hoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3628-3738","authenticated-orcid":true,"given":"Soumya","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1440-1843.2010.01751.x","article-title":"Treatment of latent tuberculosis infection: An update","volume":"15","author":"P Lobue","year":"2010","journal-title":"Respirology (Carlton, Vic)"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"H Getahun","year":"2015","journal-title":"The European respiratory journal"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15585\/mmwr.mm6511a2","article-title":"Leveling of Tuberculosis Incidence\u2014United States, 2013\u20132015","volume":"65","author":"JL Salinas","year":"2016","journal-title":"MMWR Morbidity and mortality weekly report"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1016\/j.ijid.2009.05.007","article-title":"Adherence to treatment of latent tuberculosis infection in a clinical population in New York City","volume":"14","author":"J Li","year":"2010","journal-title":"International Journal of Infectious Diseases"},{"issue":"48","key":"ref5","first-page":"1650","article-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection","volume":"60","year":"2011","journal-title":"MMWR Morbidity and mortality weekly report"},{"issue":"5","key":"ref6","first-page":"498","article-title":"Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results","volume":"12","author":"D Menzies","year":"2008","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"11","key":"ref7","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"M Farhat","year":"2006","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"key":"ref8","year":"2000"},{"issue":"5","key":"ref9","first-page":"572","article-title":"Tuberculosis morbidity in the U.S. Navy: its distribution and decline","volume":"110","author":"GW Comstock","year":"1974","journal-title":"The American review of respiratory disease"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.5588\/ijtld.14.0120","article-title":"The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review","volume":"18","author":"SK Brode","year":"2014","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"30781","DOI":"10.1038\/srep30781","article-title":"Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model","volume":"6","author":"MW Moses","year":"2016","journal-title":"Scientific reports"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2334-9-15","article-title":"Poor concordance between interferon-\u03b3 release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals","volume":"9","author":"NJ Talati","year":"2009","journal-title":"BMC Infectious Diseases"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"e96564","DOI":"10.1371\/journal.pone.0096564","article-title":"Discordance of Tuberculin Skin Test and Interferon Gamma Release Assay in Recently Exposed Household Contacts of Pulmonary TB Cases in Brazil","volume":"9","author":"R Ribeiro-Rodrigues","year":"2014","journal-title":"PloS one"},{"issue":"RR-6","key":"ref14","first-page":"1","article-title":"MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports","volume":"49","year":"2000","journal-title":"Centers for Disease Control"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"e87166","DOI":"10.1371\/journal.pone.0087166","article-title":"Factors Associated with Adherence to Treatment with Isoniazid for the Prevention of Tuberculosis amongst People Living with HIV\/AIDS: A Systematic Review of Qualitative Data","volume":"9","author":"T Makanjuola","year":"2014","journal-title":"PloS one"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1155\/2014\/349138","article-title":"Factors associated with noncompletion of latent tuberculosis infection treatment in an inner-city population in Edmonton, Alberta","volume":"25","author":"K Malejczyk","year":"2014","journal-title":"The Canadian Journal of Infectious Diseases & Medical Microbiology"},{"issue":"23","key":"ref17","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection","volume":"365","author":"TR Sterling","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/QAD.0000000000001098","article-title":"Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons","volume":"30","author":"TR Sterling","year":"2016","journal-title":"AIDS (London, England)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12879-016-1549-4","article-title":"Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review","volume":"16","author":"AL Stuurman","year":"2016","journal-title":"BMC Infectious Diseases"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.5588\/ijtld.14.0554","article-title":"Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy","volume":"19","author":"SJ Park","year":"2015","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0207582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T21:57:47Z","timestamp":1588975067000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0207582"}},"subtitle":[],"editor":[{"given":"Joan A.","family":"Cayl\u00e0","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0207582","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/207852","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]}}}